Which class of drugs reduces the adrenergic stimulation of beta receptors?

• A. Beta Blockers
• B. Alpha Blockers
• C. Calcium Channel Blockers
• D. ACE Inhibitors

Answer: (A)

Blocking beta-adrenergic receptors dampens the effects of adrenaline and noradrenaline on those receptors. Beta blockers bind to beta receptors (primarily beta-1 in the heart and kidneys) and prevent catecholamines from activating them. The result is a slower heart rate, reduced contractility, slower conduction through the AV node, and less renin release, all of which lowers blood pressure and decreases cardiac oxygen demand. This direct inhibition of beta-receptor signaling is why this class is described as reducing adrenergic stimulation of beta receptors. Other drug classes don’t target beta receptors specifically: alpha blockers act on alpha receptors, calcium channel blockers affect calcium entry to smooth muscle and cardiac cells without blocking adrenergic receptor signaling, and ACE inhibitors lower blood pressure via the RAAS system rather than receptor blockade.